Source: ERJ Open Res, 5 (2) 00250-2018; 10.1183/23120541.00250-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shuren Ma, Patrick Geraghty, Abdoulaye Dabo, Cormac McCarthy, N. Gerry McElvaney, Gerard M. Turino. Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation. ERJ Open Res, 5 (2) 00250-2018; 10.1183/23120541.00250-2018

Member's Comments

No comment yet.

Related content which might interest you: Short-term stability of the mature elastin degradation biomarker plasma desmosine and influence of smoking on plasma desmosine levels Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Plasma mitochondrial DNA as a biomarker of disease progression in idiopathic pulmonary fibrosis Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Urinary desmosines: a potential non-invasive marker of early tissue destruction in young children with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 213s Year: 2004 Total desmosines in plasma and urine correlate with lung function Source: Eur Respir J 2012; 39: 839-845 Year: 2012 KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006 Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Extracellular matrix biomarkers predict change in lung function in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease. Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Collagen degradation profile in serum of patients with COPD or IPF Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Increased cytokeratin-19 expression in fibrotic interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010